Volume 18, Number 6—June 2012
Zoonotic Disease Pathogens in Fish Used for Pedicure
To the Editor: Doctor fish (Garra rufa) are freshwater cyprinid fish that naturally inhabit river basins in central Eurasia. They are widely used in the health and beauty industries in foot spas for ichthyotherapy (Kangal fish therapy or doctor fish therapy) (Figure; Technical Appendix Figure 1 [PDF - 260 KB - 3 pages]) (1). During these sessions, patients immerse their feet or their entire bodies in the spas, allowing the fish to feed on dead skin for cosmetic reasons or for control of psoriasis, eczema, and other skin conditions.
A survey during the spring of 2011 identified 279 fish spas in the United Kingdom, and the number has probably increased since then (1). The Fish Health Inspectorate of the Centre for Environment, Fisheries & Aquaculture Science estimates that each week 15,000–20,000 G. rufa fish are imported from Indonesia and other countries in Asia into the United Kingdom through London Heathrow Airport (the main border inspection post for the import of live fish). However, ichthyotherapy has now reportedly been banned in several US states and Canada provinces because of sanitary concerns (1). In the United Kingdom, a limited number of infections after fish pedicures have been reported (1). Unfortunately, little is known about the types of bacteria and other potential pathogens that might be carried by these fish and the potential risks that they might pose to customers or to ornamental and native fish.
On April 12, 2011, the Fish Heath Inspectorate investigated a report of a disease outbreak among 6,000 G. rufa fish from Indonesia that had been supplied to UK pedicure spas. Affected fish showed clinical signs of exophthalmia and of hemorrhage around the gills, mouth, and abdomen. More than 95% of the fish died before the remaining fish were euthanized. Histopathologic examinations identified systemic bacterial infections with small gram-positive cocci, mostly in the kidneys, spleen, and liver. Bacterial isolates cultured from affected fish were identified as Streptococcus agalactiae (group B Streptococcus) according to a combination of biochemical test results (API Strep; bioMérieux, Marcy l’Étoile, France), Lancefield grouping with serotype B (Oxoid Limited, Basingstoke, UK), and molecular (partial 16S rRNA gene sequencing) testing methods.
Multilocus sequence typing of a representative isolate (11013; Technical Appendix Table [PDF - 260 KB - 3 pages]) (2) indicated that it was a sequence type (ST) 261 S. agalactiae strain (http://pubmlst.org/sagalactiae). This same ST261 profile was first identified in an isolate (ATCC 51487) from a diseased tilapia in Israel (3). The clinical appearance of the disease and the diagnostic results suggested that S. agalactiae was the causative agent of the fish illness and deaths.
To determine whether S. agalactiae and other bacterial pathogens might be carried more widely by these fish, from May 5, 2011, through June 30, 2011, the Fish Health Inspectorate of the Centre for Environment, Fisheries & Aquaculture Science visited Heathrow Airport 5 times to intercept and sample consignments of G. rufa from Indonesia. A taxonomically diverse range of bacteria were identified ( Technical Appendix [PDF - 260 KB - 3 pages], Technical Appendix Figure 2 [PDF - 260 KB - 3 pages]), including a variety of human pathogens capable of causing invasive soft tissue infections. These pathogens included Aeromonas spp (4), potentially pathogenic clinical-type Vibrio vulnificus isolates ( Technical Appendix Figure 2 [PDF - 260 KB - 3 pages]) (5), non–serotype O1 or O139 cholera toxin–negative V. cholerae isolates ( Technical Appendix Figure 2 [PDF - 260 KB - 3 pages]) (6), Mycobacteria (7), and S. agalactiae (3,8). Isolates were resistant to a variety of antimicrobial drugs, including tetracyclines, fluoroquinolones, and aminoglycosides ( Technical Appendix Table [PDF - 260 KB - 3 pages]). Other studies have also reported high levels of multidrug resistance in bacteria associated with imported ornamental fish (9).
Water is a well-recognized source of bacterial skin infections in humans. V. vulnificus can cause wound infections and primary septicemia, resulting in high mortality rates, especially among persons with predisposing risk conditions (e.g., liver disease, diabetes, or impaired immune function) (5). S. agalactiae is a common cause of skin and soft tissue infections, especially in older adults and those with chronic diseases such as diabetes mellitus (8). Although S. agalactiae ST261 is not considered to be one of the genotypes typically associated with invasive disease in humans (3), a fish-adapted strain could eventually take advantage of the opportunity afforded by repeated exposure and thereby also affect humans. Additionally, Mycobacteria spp. can occasionally cause disease in humans through contact with fish (M. marinum), and pedicure treatments have previously been associated with M. fortuitum infections (10).
Recently, the risks associated with exposure to G. rufa fish were reported to be low (1). To date, there are only a limited number of reports of patients who might have been infected by this exposure route (1). However, our study raises some concerns over the extent that these fish, or their transport water, might harbor potential zoonotic disease pathogens of clinical relevance. In particular, patients with underlying conditions (such as diabetes mellitus or immunosuppression) should be discouraged from undertaking such treatments, especially if they have obvious breaks in the skin or abrasions. This risk can probably be reduced by use of disease-free fish reared in controlled facilities under high standards of husbandry and welfare.
The UK Department for Environment Food and Rural Affairs provided funding for this study through projects FA001 and FB002.
- Health Protection Agency Fish Spa Working Group. Guidance on the management of the public health risks from fish pedicures: draft for consultation. 2011 Aug 31 [cited 2012 Mar 21]. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317131045549
- Jones N, Bohnsack JF, Takahashi S, Oliver KA, Chan MS, Kunst F, Multilocus sequence typing system for group B Streptococcus. J Clin Microbiol. 2003;41:2530–6.
- Evans JJ, Bohnsack JF, Klesius PH, Whiting AA, Garcia JC, Shoemaker CA, Phylogenetic relationships among Streptococcus agalactiae isolated from piscine, dolphin, bovine and human sources: a dolphin and piscine lineage associated with a fish epidemic in Kuwait is also associated with human neonatal infections in Japan. J Med Microbiol. 2008;57:1369–76.
- Janda JM, Abbott SL. The genus Aeromonas: taxonomy, pathogenicity, and infection. Clin Microbiol Rev. 2010;23:35–73.
- Jones MK. Oliver, JD. Vibrio vulnificus: disease and pathogenesis. Infect Immun. 2009;77:1723–33.
- Morris JG. Non–O group-1 Vibrio cholera—a look at the epidemiology of an occasional pathogen. Epidemiol Rev. 1990;12:179–91.
- Wagner D, Young LS. Nontuberculous mycobacterial infections: a clinical review. Infection. 2004;32:257–70.
- Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, Increasing burden of invasive group B streptococcal disease in non-pregnant adults, 1990–2007. Clin Infect Dis. 2009;49:85–92.
- Verner-Jeffreys DW, Welch TJ, Schwarz T, Pond MJ, Woodward MJ, Haig SJ, High prevalence of multidrug-tolerant bacteria and associated antimicrobial resistance genes isolated from ornamental fish and their carriage water. PLoS ONE. 2009;4:e8388.
- De Groote MA, Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis. 2006;42:1756–63.
- Technical Appendix. . Identities, source, and antimicrobial drug resistance profiles of bacterial isolates from Garra rufa fish shipments from Indonesia, doctor fish surrounding foot during ichthyotherapy, and agarose gel electrophoresis image... 260 KB
Suggested citation for this article: Verner-Jeffreys DW, Baker-Austin C, Pond MJ, Rimmer GSE, Kerr R, Stone D, et al. Zoonotic disease pathogens in fish used for pedicure [letter]. Emerg Infect Dis [serial on the Internet]. 2012 Jun [date cited]. http://dx.doi.org/10.3201/eid1806.111782
Please use the form below to submit correspondence to the authors or contact them at the following address:
David W. Verner-Jeffreys, Cefas Weymouth Laboratory, The Nothe, Barrack Rd, Weymouth, Dorset DT4 8UB, UK
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: May 18, 2012
- Page last updated: May 18, 2012
- Page last reviewed: May 18, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)